TARDBP and amyotrophic lateral sclerosis: Collectively, these observations indicate the importance of determining how TDP-43 folding and modification status, aging, eMI/MAPS regulators, and regulators of other proteostatic mechanisms (Keating et al., 2022) ultimately influence TDP-43 degradation and secretion, which likely have important implications for ALS disease progression.